drugset / Trial / NCT02236312
Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of the study is to evaluate the efficacy in wrinkle reduction of a single treatment of three different doses of botulinum toxin compared to placebo, in the treatment of moderate to very severe glabellar frown lines.
Timeline
- Start
- 2014-09
- Primary completion
- 2014-11
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 30 unknown | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 45 unknown | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 60 unknown | Intramuscular |
Indications
No indication recorded.